ETCTN 10483: Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR3/2 genetic alterations (GAs).
| Title: | ETCTN 10483: Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR3/2 genetic alterations (GAs). |
|---|---|
| Authors: | Jain, Rohit K., Ong, Faustine, Faltas, Bishoy Morris, Tagawa, Scott T., Jiang, Di Maria, Heiligh, Jazlyn, Naqvi, Syeda Mahrukh Hussnain, Kim, Youngchul, Pelosof, Lorraine Cheryl, Yang, Yuanquan, Graham, Laura, Arafat, Waddah, Synold, Timothy Walter, Chatwal, Monica Sheila, Zhang, Jingsong, Chadha, Jus, Sonpavde, Guru P. |
| Source: | Journal of Clinical Oncology; 2/20/2025 Supplement 5, Vol. 43, p808-808, 242p |
| Database: | Supplemental Index |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edo&genre=article&issn=0732183X&ISBN=&volume=43&issue=&date=20250221&spage=808&pages=808-1049&title=Journal of Clinical Oncology&atitle=ETCTN%2010483%3A%20Phase%20Ib%20trial%20of%20erdafitinib%20%28E%29%20combined%20with%20enfortumab%20vedotin%20%28EV%29%20following%20platinum%20and%20PD-1%2FL1%20inhibitors%20for%20metastatic%20urothelial%20carcinoma%20%28mUC%29%20with%20FGFR3%2F2%20genetic%20alterations%20%28GAs%29.&aulast=Jain%2C%20Rohit%20K.&id=DOI:10.1200/JCO.2025.43.5_suppl.808 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
|---|---|
| Header | DbId: edo DbLabel: Supplemental Index An: 183113325 RelevancyScore: 1082 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1082.12329101563 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ETCTN 10483: Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR3/2 genetic alterations (GAs). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Jain%2C+Rohit+K%2E%22">Jain, Rohit K.</searchLink><br /><searchLink fieldCode="AR" term="%22Ong%2C+Faustine%22">Ong, Faustine</searchLink><br /><searchLink fieldCode="AR" term="%22Faltas%2C+Bishoy+Morris%22">Faltas, Bishoy Morris</searchLink><br /><searchLink fieldCode="AR" term="%22Tagawa%2C+Scott+T%2E%22">Tagawa, Scott T.</searchLink><br /><searchLink fieldCode="AR" term="%22Jiang%2C+Di+Maria%22">Jiang, Di Maria</searchLink><br /><searchLink fieldCode="AR" term="%22Heiligh%2C+Jazlyn%22">Heiligh, Jazlyn</searchLink><br /><searchLink fieldCode="AR" term="%22Naqvi%2C+Syeda+Mahrukh+Hussnain%22">Naqvi, Syeda Mahrukh Hussnain</searchLink><br /><searchLink fieldCode="AR" term="%22Kim%2C+Youngchul%22">Kim, Youngchul</searchLink><br /><searchLink fieldCode="AR" term="%22Pelosof%2C+Lorraine+Cheryl%22">Pelosof, Lorraine Cheryl</searchLink><br /><searchLink fieldCode="AR" term="%22Yang%2C+Yuanquan%22">Yang, Yuanquan</searchLink><br /><searchLink fieldCode="AR" term="%22Graham%2C+Laura%22">Graham, Laura</searchLink><br /><searchLink fieldCode="AR" term="%22Arafat%2C+Waddah%22">Arafat, Waddah</searchLink><br /><searchLink fieldCode="AR" term="%22Synold%2C+Timothy+Walter%22">Synold, Timothy Walter</searchLink><br /><searchLink fieldCode="AR" term="%22Chatwal%2C+Monica+Sheila%22">Chatwal, Monica Sheila</searchLink><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Jingsong%22">Zhang, Jingsong</searchLink><br /><searchLink fieldCode="AR" term="%22Chadha%2C+Jus%22">Chadha, Jus</searchLink><br /><searchLink fieldCode="AR" term="%22Sonpavde%2C+Guru+P%2E%22">Sonpavde, Guru P.</searchLink> – Name: TitleSource Label: Source Group: Src Data: Journal of Clinical Oncology; 2/20/2025 Supplement 5, Vol. 43, p808-808, 242p |
| PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=183113325 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO.2025.43.5_suppl.808 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 242 StartPage: 808 Titles: – TitleFull: ETCTN 10483: Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR3/2 genetic alterations (GAs). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jain, Rohit K. – PersonEntity: Name: NameFull: Ong, Faustine – PersonEntity: Name: NameFull: Faltas, Bishoy Morris – PersonEntity: Name: NameFull: Tagawa, Scott T. – PersonEntity: Name: NameFull: Jiang, Di Maria – PersonEntity: Name: NameFull: Heiligh, Jazlyn – PersonEntity: Name: NameFull: Naqvi, Syeda Mahrukh Hussnain – PersonEntity: Name: NameFull: Kim, Youngchul – PersonEntity: Name: NameFull: Pelosof, Lorraine Cheryl – PersonEntity: Name: NameFull: Yang, Yuanquan – PersonEntity: Name: NameFull: Graham, Laura – PersonEntity: Name: NameFull: Arafat, Waddah – PersonEntity: Name: NameFull: Synold, Timothy Walter – PersonEntity: Name: NameFull: Chatwal, Monica Sheila – PersonEntity: Name: NameFull: Zhang, Jingsong – PersonEntity: Name: NameFull: Chadha, Jus – PersonEntity: Name: NameFull: Sonpavde, Guru P. IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 02 Text: 2/20/2025 Supplement 5 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 0732183X Numbering: – Type: volume Value: 43 Titles: – TitleFull: Journal of Clinical Oncology Type: main |
| ResultId | 1 |